EP4045039
HAMLAR INTEGRIN ALFA4BETA7 HJÁ MÖNNUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.10.2020EP published:
23.4.2025EP application number:
20875989.4
EP translation filed:
25.6.2025Grant published:
15.7.2025EPO information:
European Patent Register
Max expiry date:
15.10.2040Expiry date:
15.10.2026Next due date:
31.10.2026
Title in English:
INHIBITING HUMAN INTEGRIN ALPHA4BETA7Language of the patent:
English
Timeline
Today
16.10.2020EP application
23.4.2025EP Publication
25.6.2025Translation submitted
15.7.2025Registration published
15.10.2026Expires
Owner
Name:
Morphic Therapeutic, Inc.Address:
35 Gatehouse Drive A2, Waltham, MA 02451, US
Inventor
Name:
BURSAVICH, Matthew G.Address:
Needham, MA 02494, US
Name:
CUI, DanAddress:
Cambridge, MA 02138, US
Name:
DOWLING, James E.Address:
Lexington, MA 02420, US
Name:
HAHN, Kristopher N.Address:
Medford, MA 02155, US
Name:
HARRISON, Bryce A.Address:
Framingham, MA 01701, US
Name:
LIN, Fu-YangAddress:
Sudbury, MA 01776, US
Name:
LIPPA, Blaise S.Address:
Newton, MA 02459, US
Name:
ROGERS, Bruce N.Address:
Belmont, MA 02478, US
Name:
TROAST, Dawn M.Address:
Bedford, MA 01730, US
Name:
ZHONG, ChengAddress:
Belmont, MA 02478, US
Name:
KONZE, Kyle D.Address:
Brooklyn, NY 11215, US
Name:
GERASYUTO, Aleksey I.Address:
Flemington, NJ 08822, US
Name:
KIM, ByungchanAddress:
New York, NJ 07093, US
Name:
RAFI, SalmaAddress:
Lexington, MA 02420, US
Name:
DAY, TylerAddress:
New York, NY 10036, US
Name:
HICKEY, EugeneAddress:
Danbury, CT 06811, US
Name:
HOUANG, EvelyneAddress:
Queens, NY 11102, US
Name:
ZAHLER, RobertAddress:
Pennington, NJ 08534, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962916062 PDate:
16.10.2019Country:
US
Classification
Categories:
C07D 213/64, C07D 401/06, C07K 5/02, A61K 31/4412, A61K 31/4427, A61P 1/00, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 14.10.2025
Expires: 15.10.2026
Payer: Árnason Faktor ehf.